Shuttle Pharmaceuticals Holdings (SHPH) Amortizatization of Intangibles (2022 - 2026)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Amortizatization of Intangibles came in at $12122.0 in Q1 2026, up 85.49% year-on-year from $6535.0 in Q1 2025, and down 12.92% quarter-over-quarter from $13921.0 in Q4 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $12122.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 85.49% year-over-year to $12122.0 in Q1 2026; TTM through Mar 2026 was $659978.0, a 3.05% increase from a year earlier, with the FY2025 full-year figure at $62030.0, down 94.25% from the prior year.
  • Amortizatization of Intangibles eased to $12122.0 in Q1 2026 per SHPH's latest filing, from $13921.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $606974.0 in Q3 2022 and bottomed at -$508121.0 in Q4 2022.
  • The 5-year median for Amortizatization of Intangibles is $316967.5 (2024), against an average of $265399.4.
  • Across the five-year window, Amortizatization of Intangibles surged 337.84% in 2023 and plunged 98.53% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at -$508121.0 in 2022, then jumped by 192.17% to $468325.0 in 2023, then slumped by 47.17% to $247430.0 in 2024, then sank by 94.37% to $13921.0 in 2025, then declined by 12.92% to $12122.0 in 2026.
  • Per Business Quant, the three latest SHPH Amortizatization of Intangibles figures stand at $12122.0 (Q1 2026), $13921.0 (Q4 2025), and $247430.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Shuttle Pharmaceuticals Holdings 1.45 Mn 1.45 Mn - 12,122.00

Historic Data

Download Data
DateValue
Mar 31, 2026 12,122.00
Mar 31, 2026 12,122.00
Dec 31, 2025 13,921.00
Dec 31, 2025 13,921.00
Sep 30, 2025 247,430.00
Sep 30, 2025 247,430.00
Jun 30, 2025 386,505.00
Jun 30, 2025 386,505.00
Mar 31, 2025 6,535.00
Mar 31, 2025 6,535.00
Sep 30, 2024 247,430.00
Sep 30, 2024 247,430.00
Jun 30, 2024 386,505.00
Jun 30, 2024 386,505.00
Mar 31, 2024 445,509.00
Mar 31, 2024 445,509.00
Dec 31, 2023 468,325.00
Dec 31, 2023 468,325.00
Sep 30, 2023 538,302.00
Sep 30, 2023 538,302.00